Clinical Trial Update: VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) [Phase 4]

View source ↗

Summary

A Phase 4 feasibility study investigating vaccination to improve outcomes in chronic heart failure (VACC-HeFT) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Chronic Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-06-09